IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 265 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,508,918 | +13.3% | 2,490,600 | -2.3% | 0.18% | +3.4% |
| Q1 2023 | $15,446,885 | -6.4% | 2,548,991 | -1.5% | 0.18% | -25.2% |
| Q4 2022 | $16,509,003 | -34.6% | 2,587,618 | -4.1% | 0.24% | -26.1% |
| Q3 2022 | $25,240,000 | -15.0% | 2,699,413 | -3.6% | 0.32% | -12.3% |
| Q2 2022 | $29,704,000 | -24.3% | 2,799,642 | +17.7% | 0.37% | +27.4% |
| Q1 2022 | $39,243,000 | -52.5% | 2,378,336 | -52.1% | 0.29% | -33.6% |
| Q4 2021 | $82,619,000 | -43.0% | 4,965,096 | -22.2% | 0.43% | -30.3% |
| Q3 2021 | $144,972,000 | -27.0% | 6,380,803 | -17.4% | 0.62% | -19.8% |
| Q2 2021 | $198,527,000 | +17.3% | 7,724,788 | +44.5% | 0.78% | -6.3% |
| Q1 2021 | $169,250,000 | -17.5% | 5,345,861 | +20.8% | 0.83% | -28.9% |
| Q4 2020 | $205,269,000 | +76.7% | 4,423,910 | +25.7% | 1.17% | +13.3% |
| Q3 2020 | $116,152,000 | +54.1% | 3,519,745 | +27.8% | 1.03% | +4.3% |
| Q2 2020 | $75,365,000 | +12.3% | 2,754,568 | +22.9% | 0.99% | +56.9% |
| Q1 2020 | $67,086,000 | +82.7% | 2,241,044 | +68.9% | 0.63% | +8.8% |
| Q4 2019 | $36,718,000 | +48.7% | 1,326,509 | -2.2% | 0.58% | +31.7% |
| Q3 2019 | $24,685,000 | -20.4% | 1,356,302 | +7.3% | 0.44% | -27.8% |
| Q2 2019 | $30,996,000 | +603.8% | 1,264,096 | +173.0% | 0.61% | +424.1% |
| Q1 2019 | $4,404,000 | – | 463,070 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |